Log in
Enquire now
‌

US Patent 7074586 Quantitative assay for low abundance molecules

Patent 7074586 was granted and assigned to SOURCE PRECISION MEDICINE on July, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
‌
SOURCE PRECISION MEDICINE
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
70745860
Patent Inventor Names
John C. Cheronis0
David Trollinger0
Date of Patent
July 11, 2006
0
Patent Application Number
095957200
Date Filed
June 16, 2000
0
Patent Citations Received
‌
US Patent 12110537 Capture reactions
0
‌
US Patent 12077822 Methods for determining carrier status
0
‌
US Patent 12129514 Methods and compositions for evaluating genetic markers
0
‌
US Patent 12116618 Use of aptamers in proteomics
0
‌
US Patent 11840730 Methods and compositions for evaluating genetic markers
0
Patent Primary Examiner
‌
Long V. Le
0
Patent abstract

A method for quantitatively assaying one or more target molecules in a sample uses a nucleic acid aptamer that is specific for each target molecule. A quantitative replicative procedure is used to determine a quantity of aptamer specific for each molecule.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7074586 Quantitative assay for low abundance molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.